RHEACELL
Live / Registered — Registered — international registration renewed (as of 07 Jul 2025)
What this means for you
Registered since 12 Mar 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79229551
- Registration number
- 5694020
- Mark type
- Design + words
- Filed
- 05 Feb 2018
- Published for opposition
- 25 Dec 2018
- Registered
- 12 Mar 2019
- Attorney of record
- Claudia W. Stangle
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical [ and veterinary ] preparations for treatment of skin diseases; pharmaceutical [ and veterinary ] preparations for the treatment of vertigo; pharmaceutical [ and veterinary ] preparations for treatment of nausea; [ pharmaceutical and veterinary preparations for treatment of vomiting; pharmaceutical and veterinary preparations for treatment of migraine; ] pharmaceutical [ and veterinary ] preparations for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, [ the urinary system, ] the integumentary system [, and the reproductive system ]; pharmaceutical [ and veterinary ] preparations for treatment of blood diseases and disorders; pharmaceutical [ and veterinary ] preparations, namely, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical [ and veterinary ] preparations for wound healing; pharmaceutical [and veterinary preparations for anti-aging, namely, stem cells for medical and aesthetic purposes, [ fibroblasts for medical and aesthetic purposes, ] surgical tissue implants obtained from stem cells [ , surgical tissue implants obtained from fibroblasts ]
- Class 042 — Scientific and technological services: Scientific and technological services, namely medical and scientific research services in the fields of regenerative medicine and tissue engineering, scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, consulting services relating to scientific research in the fields of regenerative medicine and tissue engineering, providing information on medical and scientific research on pharmaceutical products, providing information in the form of expert reports relating to scientific research in the fields of regenerative medicine and tissue engineering; Industrial analysis, namely chemical analysis; research services, namely laboratory research services relating to pharmaceuticals, medical, biomedical and stem cell research in the field of regenerative medicine and tissue engineering, scientific and medical research and development for medical purposes in the field of regenerative medicine and tissue engineering, research and development services relating to new products for others, research in the field of biotechnology, research in the field of gene therapy, research and development in the field of immunology, research and development in the field of antibodies, research and development in the field of antibody technology, research and development in the field of bacteriology, research and development in the field of gene expression systems, research and development in the field of vaccines, pharmaceutical research and development services, research and development services in the field of biotechnology
- Class 044 — Medical, beauty and agricultural services: Medical services
Owner
- RHEACELL GmbH & Co. KG, Heidelberg, DE
- RHEACELL GmbH & Co. KG, 69120 Heidelberg, DE
- RHEACELL GmbH & Co. KG, 69120 Heidelberg, DE
Prosecution history
- 07 Mar 2026 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 07 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 07 Jul 2025 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 30 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Mar 2025 — TEAS SECTION 71 & 15 RECEIVED
- 12 Mar 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 04 Jan 2024 — INTERNATIONAL REGISTRATION RENEWED
- 19 Jul 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 Jul 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 Jul 2019 — FINAL DISPOSITION PROCESSED
- 12 Jun 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 12 Mar 2019 — REGISTERED-PRINCIPAL REGISTER
- 25 Dec 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Dec 2018 — PUBLISHED FOR OPPOSITION
- 05 Dec 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED